OPTIVAR Side Effects

6337093-0 | Asthenopia, Cataract, Conjunctivitis Allergic, Diplopia, Glare, Glaucoma, Headache, Madarosis, Vision Blurred
on Aug 18, 2009 Female patient from UNITED STATES , 37 years of age, was treated with Optivar (View Usage). Patient experienced the following unwanted or unexpected effects: asthenopia, cataract (What is cataract?), conjunctivitis allergic, diplopia, glare, glaucoma (What is glaucoma?), headache (What is headache?), madarosis, vision blurred. Optivar dosage: Ophthalmic. During the same period patient was treated with HYDROCODONE BIT/ACETAMINOPHEN (HYDROCODONE BITARTRATE, ACETAMINOPHEN) (View Hydrocodone Bit/acetaminophen (hydrocodone Bitartrate, Acetaminophen) Review and Hydrocodone Bit/acetaminophen (hydrocodone Bitartrate, Acetaminophen) Label ), BENZONATATE (BENSONATATE) (View Benzonatate (bensonatate) Review and Benzonatate (bensonatate) Label ), ALLEGRA (FEXOFENADINE HCL) (View Allegra (fexofenadine Hcl) Review and Allegra (fexofenadine Hcl) Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ).

6089720-3 | Dry Eye, Eye Disorder
Patient was taking Optivar (View Usage). Patient had the following side effects: dry eye, eye disorder on Feb 02, 2009 from UNITED STATES Additional patient health information: Male patient , 31 years of age, weighting 160.0 lb, was diagnosed with eye pruritus and. Optivar dosage: One Drop Once A Day Ophthalmic 4-5 Months.

6051985-1 | Agitation, Anticholinergic Syndrome, Ataxia, Confusional State, Delirium, Disorientation, Flushing, Hyperthermia
Adverse event was reported on Jan 22, 2009 by a Female patient taking Optivar (View Usage) (Dosage: 1 Gtt Both Eyes Only One Dose Ophthalmic) was diagnosed with seasonal allergy and. Location: UNITED STATES , child 10 years of age, weighting 37.92 lb, After Optivar was administered, patient had the following side effects: agitation, anticholinergic syndrome, ataxia (What is ataxia?), confusional state, delirium, disorientation, flushing, hyperthermia. Patient was hospitalized.

5834848-3 | Conjunctivitis Allergic, Eye Irritation, Eye Pruritus, Eye Swelling, Ocular Hyperaemia
on Jan 10, 2008 Female patient from UNITED STATES , 80 years of age, weighting 164.0 lb, was diagnosed with ill-defined disorder and was treated with Optivar (View Usage). Patient experienced the following unwanted or unexpected effects: conjunctivitis allergic, eye irritation, eye pruritus, eye swelling, ocular hyperaemia. Optivar dosage: 4 Drop (2 Drop, 2 In 1 D),ophthalmic.


5622695-7 | Anxiety, Ataxia, Confusional State, Disorientation, Flushing, Mental Impairment, Mydriasis, Nystagmus
on Feb 08, 2008 Female patient from UNITED STATES , child 10 years of age, was diagnosed with conjunctivitis allergic and was treated with Optivar (View Usage). Patient had the following side effects: anxiety (What is anxiety?), ataxia (What is ataxia?), confusional state, disorientation, flushing, mental impairment, mydriasis, nystagmus. Optivar dosage: 1 Drop One Dose Ocular. Patient was hospitalized.

5455643-3 | Caustic Injury, Depression, Keratoconjunctivitis Sicca, Punctate Keratitis
Patient was taking Optivar (View Usage). After Optivar was administered, patient had the following side effects: caustic injury, depression (What is depression?), keratoconjunctivitis sicca, punctate keratitis on Aug 31, 2007 from UNITED STATES Additional patient health information: Female patient , 43 years of age, was diagnosed with conjunctivitis allergic and. Optivar dosage: (2 In 1 D) Ocular Use. During the same period patient was treated with TOBRADEX (View Tobradex Review and Tobradex Label ), LOTEMAX (View Lotemax Review and Lotemax Label ), ACULAR (View Acular Review and Acular Label ), REFRESH TEAR (View Refresh Tear Review and Refresh Tear Label ). Patient was hospitalized and became disabled.

5109114-4 | Visual Acuity Reduced
Adverse event was reported on Sep 08, 2006 by a Female patient taking Optivar (View Usage) (Dosage: 1 Gt Ou Bid, Ophthalmic) was diagnosed with seasonal allergy and. Location: UNITED STATES , 28 years of age, Patient experienced the following unwanted or unexpected effects: visual acuity reduced.

5067874-5 | Dysgeusia
on Sep 29, 2005 Female patient from UNITED STATES , 35 years of age, was diagnosed with ill-defined disorder and was treated with Optivar (View Usage). Patient had the following side effects: dysgeusia. Optivar dosage: . Patient was hospitalized.

5009018-1 | Visual Acuity Reduced, Visual Disturbance
on May 05, 2006 Female patient from UNITED STATES , 28 years of age, was diagnosed with seasonal allergy and was treated with Optivar (View Usage). After Optivar was administered, patient had the following side effects: visual acuity reduced, visual disturbance. Optivar dosage: 1 Gt Ou Bid, Ophthalmic.

4989707-5 | Visual Acuity Reduced, Visual Disturbance
Patient was taking Optivar (View Usage). Patient experienced the following unwanted or unexpected effects: visual acuity reduced, visual disturbance on Apr 20, 2006 from UNITED STATES Additional patient health information: Female patient , 28 years of age, was diagnosed with seasonal allergy and. Optivar dosage: 1 Gt Ou Bid, Ophthalmic.

4905582-9 | Hypoaesthesia
Adverse event was reported on Jan 23, 2006 by a Female patient taking Optivar (View Usage) (Dosage: 2 Drops Each Eye, Once) was diagnosed with ill-defined disorder and. Location: UNITED STATES , 37 years of age, Patient had the following side effects: hypoaesthesia. Patient was hospitalized.